Fundraising Fox

Brigham Hyde

Investor

Venture Partner at Audere Capital

New York, New York, United States

About

Brigham is co-founder and CEO of Atropos Health, an AI-driven digital health platform, and co-founder and CEO of Concert AI, a $2 billion company providing clinical cancer data and analytics. He previously served as a partner at Symphony AI.

Experience

  1. Atropos HealthChief Executive Officercurrent2022 β€” presentNew York, New York, United States
  2. Atropos HealthCo-Founder Board Membercurrent2020 β€” presentSan Francisco Bay Area
  3. Audere Capital LLCVenture Partnercurrent2023 β€” presentNew York City Metropolitan Area
  4. EVERSANASpecial Advisor2022 β€” 2023New York, New York, United States
  5. EVERSANAPresident2020 β€” 2022New York City Metropolitan Area
  6. ForbesOfficial Member of Forbes Technology Council2018 β€” 2022
  7. Massachusetts Institute of Technology (MIT)Research Affiliate2016 β€” 2022Cambridge, MA
  8. Tufts UniversityAdjunct Professor of Pharmacology and Experimental Therapeutics2012 β€” 2022Greater Boston
  9. SymphonyAIPartner2017 β€” 2019Greater New York City Area
  10. Concerto HealthAICo-Founder President2017 β€” 2019New York City Metropolitan Area
  11. Precision Health AI (Now Concerto Health AI)CEO2017 β€” 2019New York City Metropolitan Area
  12. Decision ResourcesChief Data Officer2014 β€” 2017Burlington, MA
  13. Decision ResourcesSenior Vice President of Analytics2014 β€” 2017Greater Boston
  14. Relay Technology Management, Inc.Chief Executive Officer2013Greater Boston
  15. Relay Technology Management, Inc.Managing Director2011 β€” 2013
  16. Cowen and CompanyEquity Research Analyst2009 β€” 2011
  17. Boston University Medical CenterPost-Doctoral Fellow Hematology2009
  18. Relay Technology Management, Inc.Co- Founder, Director of Licensing2008 β€” 2009
  19. Leerink SwannContracted Consultant2008
  20. Wolfe Laboratories, Inc.Intern2001 β€” 2004
  21. WR GraceIntern2000

Skills & more

Therapeutics54Technology Transfer76Chemistry31Biopharmaceuticals22Life Sciences45Investment Banking13Research21Start-ups32Science26Licensing12Analytics13Healthcare12
+12 moreFundingBiotechnologyFDAFinancial ModelingClinical TrialsEquity ResearchEntrepreneurshipData AnalysisExcelPowerPointMicrosoft ExcelManagement
  • Series 63 β€” FINRA
  • Series 87 β€” FINRA
  • Series 86 β€” FINRA
  • Series 7 β€” Finra

From Brigham's professional profile.

Colleagues at Audere Capital

Frequently asked questions

Who is Brigham Hyde?
Brigham is co-founder and CEO of Atropos Health, an AI-driven digital health platform, and co-founder and CEO of Concert AI, a $2 billion company providing clinical cancer data and analytics. He previously served as a partner at Symphony AI.
Where does Brigham Hyde work?
Brigham Hyde is Venture Partner at Audere Capital.
Where did Brigham Hyde go to school?
Brigham Hyde studied at Tufts University School of Medicine (Ph.D., Pharmacology and Experimental Therapeutics); Northeastern University (BS, Chemistry); Stowe High School.

Founder mafias

Same school

Shared employers